What are the treatment options for coxalgia (hip pain)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Coxalgia (Hip Pain)

The optimal management of hip pain (coxalgia) requires a combination of non-pharmacological and pharmacological treatment modalities tailored to the individual's specific condition, pain intensity, and functional limitations. 1

Treatment Algorithm

First-Line Treatments

  • Non-pharmacological approaches should be initiated for all patients with hip pain and include:

    • Regular education about the condition and self-management strategies 1
    • Exercise therapy to improve function and reduce pain 1
    • Assistive devices such as walking sticks or canes when needed 1
    • Weight reduction for patients who are overweight or obese 1
  • Pharmacological first-line treatment:

    • Paracetamol (acetaminophen) up to 4g/day is the oral analgesic of first choice for mild to moderate hip pain due to its efficacy and safety profile 1
    • Should be used as the preferred long-term oral analgesic if effective 1

Second-Line Treatments

  • NSAIDs should be added or substituted when paracetamol provides inadequate pain relief:
    • Use the lowest effective dose (e.g., ibuprofen 1200-3200mg daily) 1, 2
    • For patients with increased gastrointestinal risk, use either:
      • Non-selective NSAIDs plus a gastroprotective agent 1
      • A selective COX-2 inhibitor 1
    • NSAIDs should be used with caution in patients with cardiovascular, renal, or hepatic conditions 2

Third-Line Treatments

  • Opioid analgesics (with or without paracetamol) should be considered when:

    • NSAIDs are contraindicated
    • NSAIDs are ineffective
    • NSAIDs are poorly tolerated 1
    • Be aware that opioids may cause more side effects including constipation, dizziness, and drowsiness 1
  • Symptomatic slow-acting drugs for osteoarthritis (SYSADOA) may be considered:

    • Options include glucosamine sulfate, chondroitin sulfate, diacerhein, avocado soybean unsaponifiable, and hyaluronic acid 1
    • These have symptomatic effects and low toxicity, but effect sizes are small 1

Interventional Treatments

  • Intra-articular steroid injections (guided by ultrasound or x-ray) may be considered for patients with acute flares unresponsive to analgesics and NSAIDs 1

  • Physical therapy interventions may include:

    • Manual therapy techniques 1
    • Targeted exercises for hip and trunk muscle strengthening 1
    • Functional movement training 1

Surgical Options

  • Osteotomy and joint-preserving procedures should be considered in young adults with symptomatic hip OA, especially with dysplasia or varus/valgus deformity 1

  • Joint replacement (total hip arthroplasty) should be considered for patients with:

    • Radiographic evidence of hip OA
    • Refractory pain and disability despite conservative management 1, 3

Special Considerations

  • Treatment should be tailored according to:

    • Hip-specific risk factors (obesity, mechanical factors, activity level, dysplasia) 1
    • General risk factors (age, comorbidities, co-medications) 1
    • Pain intensity and functional limitations 1
    • Structural damage extent and location 1
    • Patient preferences and goals 1
  • Monitoring treatment response:

    • Use appropriate patient-reported outcome measures to assess pain and function 1
    • Evaluate physical impairment measures (range of motion, strength) 1
    • Consider psychosocial factors that may influence pain perception and treatment outcomes 1

Common Pitfalls to Avoid

  • Overreliance on medication alone without addressing non-pharmacological approaches 1
  • Prolonged use of high-dose NSAIDs without monitoring for gastrointestinal, cardiovascular, or renal adverse effects 1, 2
  • Inadequate pain control leading to reduced mobility and physical deconditioning 1
  • Delayed referral for surgical evaluation when conservative measures fail to provide adequate relief 1
  • Failure to diagnose specific causes of hip pain that may require targeted treatment (e.g., inflammatory arthritis, avascular necrosis, labral tears) 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Total hip replacement as a result of coxalgia: about 10 cases].

The Pan African medical journal, 2016

Research

[Coxalgia].

Revue medicale de Liege, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.